摘要
目的 :总结综述我国在细胞工程制药相关技术领域 ,如细胞融合、核移植、染色体改造、转基因和大规模细胞培养等方面的研究现状和未来的发展前景。方法 :文献调研与数据整理。结果 :我国细胞工程制药相关研究起步晚 ,发展快 ,前景广阔。结论 :目前研究重点应放在人源化抗体。
OBJECTIVE:To review the present and prospecting of cell engineering pharmacy in China.METHOD:According to the recent literatures on this field, animal cell engineering and plant cell engineering pharmacy were summarized and evaluated.RESULTS:Cell engineering pharmacy in China has been developing but need more supports especially in the research of traditional Chinese herbal medicine.CONCLUSION:Cell engineering pharmacy in China possesses tremendous developmental foreground.
出处
《中国现代应用药学》
CAS
CSCD
北大核心
2002年第4期278-281,共4页
Chinese Journal of Modern Applied Pharmacy
基金
清华大学.香港浸会大学中药现代化研究联合实验室和清华大学 985计划的支持
关键词
细胞工程
细胞融合
核移植
染色体改造
转基因
细胞培养
cell engineering pharmacy, traditional Chinese medicine, transgene, biological reactor
